Learn More
Medchemexpress LLC ADTL-SA1215 | 782387-91-1 | 98.96% | 657.32 | 50 MG

Supplier: Medchemexpress LLC HY13974250MG
ADTL-SA1215 is a novel, first-in-class, and specific small-molecule activator of Sirtuin-3 (SIRT3). This compound is recognized for its role in modulating autophagy, particularly in the context of triple-negative breast cancer. It has demonstrated antiproliferative activity against various human cancer cell lines, including HL-60, MCF7, and MDA-MB-231. ADTL-SA1215 is intended solely for research purposes.
- First-in-class specific small-molecule activator of SIRT3.
- Modulates autophagy.
- Exhibits activity in triple negative breast cancer models.
- Demonstrates antiproliferative effects on human HL-60, MCF7, MDA-MB-231, and U-937 cell lines.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.